Skip to main content
Study: C-peptide testing important after diabetes diagnosis

UK researchers recruited 757 patients with type 1 diabetes duration of at least 3 years and found that 13 of 14 of those whose C-peptide levels greater than 900 pmol/L were reclassified as having type 2 diabetes, while other patients at varying C-peptide levels were reclassified as having different genetic types of diabetes. The findings, presented at the Diabetes UK Professional Conference, also showed that some patients with diabetic ketoacidosis actually had type 2 diabetes.

Full Story: